Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03574961 · ClinicalTrials.gov registry record · NA

E-Support Groups in Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT03574961 is a NA study of Multiple Sclerosis that has completed, run by Columbia University. The registered enrollment target is 30 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03574961, a NA study of Multiple Sclerosis, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Primary objectives: * To determine the feasibility of program (80% retained with 75% overall attendance, and completed immediate follow-up questionnaires from 75% of participants). * To determine the efficacy of program (evaluated by decreased loneliness, operationalized as decreased total score on the UCLA Loneliness Scale from pre to post intervention). Secondary objective: * To determine whether program will affect depression and quality of life.

Conditions Studied

Interventions

  • BEHAVIORAL e-Support group
  • BEHAVIORAL e-Journaling placebo

Study Locations (1)

New York

  • Columbia University Medical Center (MS Center) - New York

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2018-05-10
Est. Completion 2019-06-30
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT03574961

The ClinicalTrials.gov registry entry for NCT03574961 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (95% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which e-Support group is the first listed.

NCT03574961 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03574961 about?

NCT03574961 is a clinical study titled "E-Support Groups in Multiple Sclerosis". Primary objectives: * To determine the feasibility of program (80% retained with 75% overall attendance, and completed immediate follow-up questionnaires from 75% of participants). * To determine the efficacy of program (evaluated by decreased loneliness, operationalized as decreased total score on...

What is the current status of trial NCT03574961?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-05-10. Estimated completion is 2019-06-30.

What conditions does trial NCT03574961 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT03574961?

The interventions under investigation include: e-Support group (BEHAVIORAL), e-Journaling placebo (BEHAVIORAL).

Who is sponsoring clinical trial NCT03574961?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03574961 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.